Notice Number: NOT-EB-20-004
Key Dates
Release Date: March 24, 2020
PA-18-935
Issued by
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Purpose
The purpose of this Notice is to inform applicants that the National Institute of Biomedical Imaging and Bioengineering (NIBIB) will participate, effective immediately, in PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)".
The following changes and updates are made to PA-18-935 (shown in italics) to reflect NIBIB participation in this FOA.
Part 1. Overview Information
Components of Participating Organizations
National Institute on Aging (NIA)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)
National Institute of Environmental Health Sciences (NIEHS)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.866, 93.855, 93.279, 93.847, 93.242, 93.113, 93.272, 93.286
All other aspects of this Notice remain the same.
Inquiries
Please direct all inquiries to:
Todd Merchak
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Telephone: 301-496-8592
Email: merchakt@mail.nih.gov
and Human Services (HHS)
